Neuland Labs Q2 FY27 Profit Falls 47% as Margins Narrow
Neuland Labs’ Q2 FY27 profit fell 47% to ₹51.1 crore as income slipped 11%, while the API maker opened a new peptide plant and bought land in Kakinada.
Neuland Labs’ Q2 FY27 profit fell 47% to ₹51.1 crore as income slipped 11%, while the API maker opened a new peptide plant and bought land in Kakinada.
Laurus Labs reported Q2 FY27 net profit of ₹441 crore, up 126%, on revenue of ₹2,206 crore, as CDMO revenue rose 75% to ₹904 crore and EBITDA margin widened to 34.5%. The Hyderabad drugmaker also agreed to take a 60% stake in Montreal-based Galenvs Sciences to deepen its oligonucleotide capabilities.